Clinical Trial Update: Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

View source ↗

Summary

This clinical trial update reports sustained loss of hepatitis B surface antigen (HBsAg) and associated viral response in patients treated with interferon for c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Status: UNKNOWN